List of Excipients in API abacavir and lamivudine
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing abacavir and lamivudine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 | CELLULOSE, MICROCRYSTALLINE |
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 | FD&C YELLOW NO. 6 |
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 | FERRIC OXIDE YELLOW |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for abacavir and lamivudine
Excipient focus: CELLULOSE, MICROCRYSTALLINE
abacavir and lamivudine drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
abacavir and lamivudine drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | abacavir and lamivudine | 70710-1049 |
| Zydus Lifesciences Limited | abacavir and lamivudine | 70771-1053 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
abacavir and lamivudine drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | abacavir and lamivudine | 68180-288 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
abacavir and lamivudine drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | abacavir and lamivudine | 70710-1049 |
| Zydus Lifesciences Limited | abacavir and lamivudine | 70771-1053 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
abacavir and lamivudine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | abacavir and lamivudine | 70710-1049 |
| Zydus Lifesciences Limited | abacavir and lamivudine | 70771-1053 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
abacavir and lamivudine drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharma | abacavir and lamivudine | 35573-402 |
| Aurobindo Pharma Limited | abacavir and lamivudine | 65862-900 |
| Zydus Pharmaceuticals USA Inc | abacavir and lamivudine | 70710-1049 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
abacavir and lamivudine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| AvKARE | abacavir and lamivudine | 42291-115 |
| Zydus Pharmaceuticals USA Inc | abacavir and lamivudine | 70710-1049 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| Burel Pharma | abacavir and lamivudine | 35573-402 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
abacavir and lamivudine drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Burel Pharma | abacavir and lamivudine | 35573-402 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
abacavir and lamivudine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | abacavir and lamivudine | 68180-288 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
abacavir and lamivudine drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Burel Pharma | abacavir and lamivudine | 35573-402 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| Lupin Pharmaceuticals Inc | abacavir and lamivudine | 68180-288 |
| Cipla USA Inc | abacavir and lamivudine | 69097-362 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
abacavir and lamivudine drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| Cipla USA Inc | abacavir and lamivudine | 69097-362 |
| Zydus Pharmaceuticals USA Inc | abacavir and lamivudine | 70710-1049 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Burel Pharma | abacavir and lamivudine | 35573-402 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
abacavir and lamivudine drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
abacavir and lamivudine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | abacavir and lamivudine | 68180-288 |
| Zydus Pharmaceuticals USA Inc | abacavir and lamivudine | 70710-1049 |
| Zydus Lifesciences Limited | abacavir and lamivudine | 70771-1053 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
abacavir and lamivudine drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | abacavir and lamivudine | 68180-288 |
| Zydus Pharmaceuticals USA Inc | abacavir and lamivudine | 70710-1049 |
| Zydus Lifesciences Limited | abacavir and lamivudine | 70771-1053 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
abacavir and lamivudine drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
abacavir and lamivudine drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| Lupin Pharmaceuticals Inc | abacavir and lamivudine | 68180-288 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Burel Pharma | abacavir and lamivudine | 35573-402 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
abacavir and lamivudine drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | abacavir and lamivudine | 70710-1049 |
| Zydus Lifesciences Limited | abacavir and lamivudine | 70771-1053 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
abacavir and lamivudine drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| Cipla USA Inc | abacavir and lamivudine | 69097-362 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Burel Pharma | abacavir and lamivudine | 35573-402 |
| Burel Pharmaceuticals Inc | abacavir and lamivudine | 35573-430 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
abacavir and lamivudine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | abacavir and lamivudine | 68180-288 |
| Cipla USA Inc | abacavir and lamivudine | 69097-362 |
| Zydus Pharmaceuticals USA Inc | abacavir and lamivudine | 70710-1049 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
abacavir and lamivudine drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | abacavir and lamivudine | 69097-362 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
abacavir and lamivudine drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | abacavir and lamivudine | 69097-362 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
abacavir and lamivudine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abacavir and lamivudine | 0093-5382 |
| Camber Pharmaceuticals Inc | abacavir and lamivudine | 31722-838 |
| Macleods Pharmaceuticals Limited | abacavir and lamivudine | 33342-440 |
| >Company | >Ingredient | >NDC |
abacavir and lamivudine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
